TOSLA, in partnership with biotechnology company Geltor, has introduced a ready-to-drink liquid supplement called the Signaling Collagen Shot. This innovation features PrimaColl, a vegan type 21 signaling collagen polypeptide produced through biodesign.
The TOSLA x Geltor Signaling Collagen Shot comes as a 30-millilitre daily liquid. Available in a cherry-raspberry flavor, the formula contains one gram of PrimaColl per bottle and is supported by TOSLA’s VELIOUS Flavor Technology to create a smooth and palatable experience.
The clinical data from a 12-week randomized, double-blind, placebo-controlled study, which involved 170 women, showed that 80% to 90% of participants experienced improvements in skin firmness, elasticity, moisturization, and wrinkle depth when consuming one to two and a half grams of the Signaling Collagen Shot daily.
Image Credit: TOSLA x Geltor
Key Themes Behind This Trend
- Plant-based Biodesign Supplements
- A shift toward lab-designed vegan proteins like PrimaColl indicates potential for entirely animal-free functional ingredients to replace traditional animal-derived actives in personal care and nutrition.
- Daily Microdose Beauty Shots
- Ready-to-drink 30-millilitre formats delivering precise microdoses of bioactive compounds suggest a move toward convenient, compliance-friendly dosing that could redefine supplement delivery paradigms.
- Clinically Validated Cosmetic Nutrition
- The availability of randomized, double-blind placebo-controlled data tying ingestible formulations to measurable skin improvements points to a convergence of clinical science and beauty product marketing.
Where This Applies
- Nutraceuticals
- Formulations combining biodesigned peptides and flavor tech create opportunities for product lines that blend medical-grade efficacy with mainstream consumer palatability.
- Beverage Consumer Packaged Goods
- The emergence of functional shots as a beverage category implies potential for new SKUs that prioritize single-serve efficacy over traditional refreshment metrics.
- Biotechnology Manufacturing
- Scalable fermentation and precision peptide production capabilities could enable contract manufacturers to supply tailored signaling proteins for multiple brands and applications.
